Exact Mass: 392.2311

Exact Mass Matches: 392.2311

Found 102 metabolites which its exact mass value is equals to given mass value 392.2311, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Kalihinol A

(4aalpha,8abeta)-8beta-[(2,6,6-Trimethyl-5beta-chlorotetrahydro-2H-pyran)-2alpha-yl]-1alpha,5alpha-diisocyano-2,5-dimethyldecahydronaphthalen-2beta-ol

C22H33ClN2O2 (392.223)


   

Trospium

3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-8λ⁵-azaspiro[bicyclo[3.2.1]octane-8,1-pyrrolidin]-8-ylium

C25H30NO3+ (392.2226)


Trospium is only found in individuals that have used or taken this drug. It is a urinary antispasmodic. It is sold under the brand name Sanctura in the US, and as Trosec in Canada. [Wikipedia]Trospium antagonizes the effect of acetylcholine on muscarinic receptors in cholinergically innervated organs. Its parasympatholytic action reduces the tonus of smooth muscle in the bladder.

   

Methyl (9Z)-6'-oxo-6,5'-diapo-6-carotenoate

Methyl (4Z,6E,8E,10E,12E,14E,16E,18E)-4,8,13,17-tetramethyl-20-oxohenicosa-2,4,6,8,10,12,14,16,18-nonaenoic acid

C26H32O3 (392.2351)


Methyl (9Z)-6-oxo-6,5-diapo-6-carotenoate is a constituent of Bixa orellana (annatto) Constituent of Bixa orellana (annatto).

   

CPA(16:0/0:0)

(2-Hydroxy-2-oxo-1,3,2λ⁵-dioxaphospholan-4-yl)methyl hexadecanoic acid

C19H37O6P (392.2328)


cPA(16:0/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis. [HMDB] cPA(16:0/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis.

   

N,N'-Dibenzhydrylethane-1,2-diamine

(diphenylmethyl)({2-[(diphenylmethyl)amino]ethyl})amine

C28H28N2 (392.2252)


AMN082 free base, a selective, orally active, and brain penetrant mGluR7 agonist, directly activates receptor signaling via an allosteric site in the transmembrane domain. AMN082 free base potently inhibits cAMP accumulation and stimulates GTPγS binding (EC50 values, 64-290 nM) at transfected mammalian cells expressing mGluR7. AMN082 free base shows selectivity over other mGluR subtypes and selected ionotropic glutamate receptors. Antidepressant effects[1][2].

   

N'-[(6-Oxo-5-prop-2-enyl-1-cyclohexa-2,4-dienylidene)methyl]-2-[4-(phenylmethyl)-1-piperazinyl]acetohydrazide

N-[(6-oxo-5-prop-2-enyl-1-cyclohexa-2,4-dienylidene)methyl]-2-[4-(phenylmethyl)-1-piperazinyl]acetohydrazide

C23H28N4O2 (392.2212)


   

(-)-12,12-Methylenedicytisine

(-)-12,12-Methylenedicytisine

C23H28N4O2 (392.2212)


   

Sedumoside B

Sedumoside B

C19H36O8 (392.241)


   
   

Turpinionoside C

Turpinionoside C

C19H36O8 (392.241)


   

Candenatenin F

Candenatenin F

C26H32O3 (392.2351)


   

Sedumoside A1

Sedumoside A1

C19H36O8 (392.241)


   
   

Sedumoside A3

Sedumoside A3

C19H36O8 (392.241)


   

3-Oxoandrost-4-en-17-yl benzoate

3-Oxoandrost-4-en-17-yl benzoate

C26H32O3 (392.2351)


   

Meliaionoside A

Meliaionoside A

C19H36O8 (392.241)


   

Melia-ionoside B

Melia-ionoside B

C19H36O8 (392.241)


   

dihydroalangionoside A

dihydroalangionoside A

C19H36O8 (392.241)


   

triptiliocoumarin

triptiliocoumarin

C26H32O3 (392.2351)


   

Melia-ioniside B

Melia-ioniside B

C19H36O8 (392.241)


   

(3S,5S,6R,9S)-megastigman-3,6,9-triol 3-O-beta-D-(-)-glucopyranoside|iso-dihydrodendranthemoside A|NSC# 742189

(3S,5S,6R,9S)-megastigman-3,6,9-triol 3-O-beta-D-(-)-glucopyranoside|iso-dihydrodendranthemoside A|NSC# 742189

C19H36O8 (392.241)


   
   

Melia-ioniside A

Melia-ioniside A

C19H36O8 (392.241)


   

8-[3-(2-dimethylaminoethyl)-5-hydroxy-1h-indol-4-yl]-1-methyl-2,3,8,8a-tetrahydro-1h-pyrrolo[2,3-b]indol-3a-ol

8-[3-(2-dimethylaminoethyl)-5-hydroxy-1h-indol-4-yl]-1-methyl-2,3,8,8a-tetrahydro-1h-pyrrolo[2,3-b]indol-3a-ol

C23H28N4O2 (392.2212)


   
   

4alpha-angeloyloxy-5beta-hydroxy-13beta-methoxylupanine

4alpha-angeloyloxy-5beta-hydroxy-13beta-methoxylupanine

C21H32N2O5 (392.2311)


   
   

15-Hydroxy Lubiprostone

15-Hydroxy Lubiprostone

C20H34F2O5 (392.2374)


   

N-[(6-oxo-5-prop-2-enyl-1-cyclohexa-2,4-dienylidene)methyl]-2-[4-(phenylmethyl)-1-piperazinyl]acetohydrazide

N-[(6-oxo-5-prop-2-enyl-1-cyclohexa-2,4-dienylidene)methyl]-2-[4-(phenylmethyl)-1-piperazinyl]acetohydrazide

C23H28N4O2 (392.2212)


   

Trospium

Trospium

[C25H30NO3]+ (392.2226)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3030

   

C19H36O8_[5-Hydroxy-2-(3-hydroxybutyl)-3,3-dimethylcyclohexyl]methyl beta-D-glucopyranoside

NCGC00380670-01_C19H36O8_[5-Hydroxy-2-(3-hydroxybutyl)-3,3-dimethylcyclohexyl]methyl beta-D-glucopyranoside

C19H36O8 (392.241)


   

16:0 cyclic LPA

1-hexadecanoyl-sn-glycero-2,3-cyclic-phosphate

C19H37O6P (392.2328)


   

13,14-dihydro-16,16-difluoro Prostaglandin F2&alpha

9α,11α,15S-trihydroxy-16,16-difluoro-prosta-5Z-en-1-oic acid

C20H34F2O5 (392.2374)


   

CPA(16:0)

1-hexadecanoyl-sn-glycero-2,3-cyclic-phosphate

C19H37O6P (392.2328)


   

13,14-dihydro-16,16-difluoro Prostaglandin E1

9-oxo-11α,15S-dihydroxy-16,16-difluoro-prostan-1-oic acid

C20H34F2O5 (392.2374)


   

PAC-1

4-(phenylmethyl)-[[2-hydroxy-3-(2-propenyl)phenyl]methylene]hydrazide, 1-piperazineacetic acid

C23H28N4O2 (392.2212)


C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent

   

Trospium

3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-8$l^{5}-azaspiro[bicyclo[3.2.1]octane-8,1-pyrrolidin]-8-ylium

C25H30NO3+ (392.2226)


G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

Methyl (9Z)-6'-oxo-6,5'-diapo-6-carotenoate

methyl (2E,4Z,6E,8E,10E,12E,14E,16E,18E)-4,8,13,17-tetramethyl-20-oxohenicosa-2,4,6,8,10,12,14,16,18-nonaenoate

C26H32O3 (392.2351)


   

1-palmitoleyl glycerone-3-phosphate

1-(9Z-hexadecenyl)-glycerone 3-phosphate

C19H37O6P (392.2328)


   

CPA 16:0

1-hexadecanoyl-sn-glycero-2,3-cyclic-phosphate

C19H37O6P (392.2328)


   

Desfluoro Risperidone

Desfluoro Risperidone

C23H28N4O2 (392.2212)


   

Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclohexyl-N-(3-methoxyphenyl)- (9CI)

Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclohexyl-N-(3-methoxyphenyl)- (9CI)

C23H28N4O2 (392.2212)


   

methyl (2s)-2-[[(2s)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]amino]-3-phenylpropanoate

methyl (2s)-2-[[(2s)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]amino]-3-phenylpropanoate

C21H32N2O5 (392.2311)


   

TESTOSTERONE BENZOATE

TESTOSTERONE BENZOATE

C26H32O3 (392.2351)


   

Nonyloxytryptamine oxalate

Nonyloxytryptamine oxalate

C21H32N2O5 (392.2311)


   

(E)-N-(3-allyl-2-hydroxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide

(E)-N-(3-allyl-2-hydroxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide

C23H28N4O2 (392.2212)


   

5-Nonyloxytryptamine oxalate

5-Nonyloxytryptamine oxalate

C21H32N2O5 (392.2311)


   

13,14-dihydro-16,16-difluoro Prostaglandin F2alpha

13,14-dihydro-16,16-difluoro Prostaglandin F2alpha

C20H34F2O5 (392.2374)


   

Testosterone, benzoate

Testosterone, benzoate

C26H32O3 (392.2351)


   

1-Palmitylglycerone 3-phosphate(2-)

1-Palmitylglycerone 3-phosphate(2-)

C19H37O6P-2 (392.2328)


   

2-oxo-3-[(2E,6E)-farnesyl]-6-(pyridin-3-yl)-2H-pyran-4-olate

2-oxo-3-[(2E,6E)-farnesyl]-6-(pyridin-3-yl)-2H-pyran-4-olate

C25H30NO3- (392.2226)


   

Pirmenol hydrochloride hydrate

Pirmenol hydrochloride hydrate

C22H33ClN2O2 (392.223)


   

AMN082 free base

N,N-Dibenzhydrylethane-1,2-diamine

C28H28N2 (392.2252)


AMN082 free base, a selective, orally active, and brain penetrant mGluR7 agonist, directly activates receptor signaling via an allosteric site in the transmembrane domain. AMN082 free base potently inhibits cAMP accumulation and stimulates GTPγS binding (EC50 values, 64-290 nM) at transfected mammalian cells expressing mGluR7. AMN082 free base shows selectivity over other mGluR subtypes and selected ionotropic glutamate receptors. Antidepressant effects[1][2].

   

1-Hexadecanoyl-cyclophosphatidic acid

1-Hexadecanoyl-cyclophosphatidic acid

C19H37O6P (392.2328)


   

1-Palmitylglycerone 3-phosphate(2-)

1-Palmitylglycerone 3-phosphate(2-)

C19H37O6P (392.2328)


A 1-alkylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-palmitylglycerone 3-phosphate; major species at pH 7.3.

   

1-hexadecanoyl-sn-glycero-2,3-cyclic-phosphate

1-hexadecanoyl-sn-glycero-2,3-cyclic-phosphate

C19H37O6P (392.2328)


   
   
   

LPA P-16:1 or LPA O-16:2

LPA P-16:1 or LPA O-16:2

C19H37O6P (392.2328)


   
   

Gboxin

Gboxin

C22H33ClN2O2 (392.223)


Gboxin is an oxidative phosphorylation (OXPHOS) inhibitor that targets glioblastoma. Gboxin inhibits the activity of F0F1 ATP synthase. Antitumour activity[1].

   

(1s,2s,4ar,5r,8r,8ar)-8-[(2s,5r)-5-chloro-2,6,6-trimethyloxan-2-yl]-1,5-diisocyano-2,5-dimethyl-octahydronaphthalen-2-ol

(1s,2s,4ar,5r,8r,8ar)-8-[(2s,5r)-5-chloro-2,6,6-trimethyloxan-2-yl]-1,5-diisocyano-2,5-dimethyl-octahydronaphthalen-2-ol

C22H33ClN2O2 (392.223)


   

(2r,3r,4s,5s,6r)-2-{[(1r,2s,3s,4s)-3-[(3r)-3-hydroxybutyl]-4-(hydroxymethyl)-2,4-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2s,3s,4s)-3-[(3r)-3-hydroxybutyl]-4-(hydroxymethyl)-2,4-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

11-({6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-11-yl}methyl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

11-({6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-11-yl}methyl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C23H28N4O2 (392.2212)


   

8-(3,7-dimethylocta-2,6-dien-1-yl)-3-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-7-ol

8-(3,7-dimethylocta-2,6-dien-1-yl)-3-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-7-ol

C26H32O3 (392.2351)


   

(3r)-8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-7-ol

(3r)-8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-7-ol

C26H32O3 (392.2351)


   

(3r,4s,5r,6r)-2-[(2s)-2-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(3r,4s,5r,6r)-2-[(2s)-2-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

(2r,3r,4s,5r,6r)-2-{[(2r)-1-hydroxy-4-[(1r,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(2r)-1-hydroxy-4-[(1r,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

(2r,3r,4s,5s,6r)-6-({[(1s,4r,5s)-4-[(3r)-3-hydroxybutyl]-5-(hydroxymethyl)-3,3-dimethylcyclohexyl]oxy}methyl)oxane-2,3,4,5-tetrol

(2r,3r,4s,5s,6r)-6-({[(1s,4r,5s)-4-[(3r)-3-hydroxybutyl]-5-(hydroxymethyl)-3,3-dimethylcyclohexyl]oxy}methyl)oxane-2,3,4,5-tetrol

C19H36O8 (392.241)


   

2-{[4-(3-hydroxybutyl)-5-(hydroxymethyl)-3,3-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[4-(3-hydroxybutyl)-5-(hydroxymethyl)-3,3-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

2-({4-[4-hydroxy-6-(hydroxymethyl)-2,2-dimethylcyclohexyl]butan-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({4-[4-hydroxy-6-(hydroxymethyl)-2,2-dimethylcyclohexyl]butan-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

(1r,2r,5s,8s)-8-[(2r,5r)-5-chloro-2,6,6-trimethyloxan-2-yl]-1,5-diisocyano-2,8-dimethyl-octahydronaphthalen-2-ol

(1r,2r,5s,8s)-8-[(2r,5r)-5-chloro-2,6,6-trimethyloxan-2-yl]-1,5-diisocyano-2,8-dimethyl-octahydronaphthalen-2-ol

C22H33ClN2O2 (392.223)


   

(2r,3r,4s,5s,6r)-6-({[(2r)-4-[(1r,4s,6s)-4-hydroxy-6-(hydroxymethyl)-2,2-dimethylcyclohexyl]butan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol

(2r,3r,4s,5s,6r)-6-({[(2r)-4-[(1r,4s,6s)-4-hydroxy-6-(hydroxymethyl)-2,2-dimethylcyclohexyl]butan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol

C19H36O8 (392.241)


   

(2e,4z)-n-(1-{[(1z)-1,3-dimethoxy-3-oxoprop-1-en-2-yl]-c-hydroxycarbonimidoyl}eth-1-en-1-yl)-2,10-dimethylundeca-2,4-dienimidic acid

(2e,4z)-n-(1-{[(1z)-1,3-dimethoxy-3-oxoprop-1-en-2-yl]-c-hydroxycarbonimidoyl}eth-1-en-1-yl)-2,10-dimethylundeca-2,4-dienimidic acid

C21H32N2O5 (392.2311)


   

(2r,3r,4s,5r,6r)-2-[(2s)-2-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-[(2s)-2-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

(1s,2r,4r,5s,9s,10s,12r)-5-hydroxy-12-methoxy-6-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (2z)-2-methylbut-2-enoate

(1s,2r,4r,5s,9s,10s,12r)-5-hydroxy-12-methoxy-6-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (2z)-2-methylbut-2-enoate

C21H32N2O5 (392.2311)


   

(1r,9s)-11-{[(1r,9s)-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-11-yl]methyl}-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

(1r,9s)-11-{[(1r,9s)-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-11-yl]methyl}-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C23H28N4O2 (392.2212)


   

2-{[4-(3-hydroxybutyl)-3-(hydroxymethyl)-3,5-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[4-(3-hydroxybutyl)-3-(hydroxymethyl)-3,5-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

8-[5-(2-chloropropan-2-yl)-2-methyloxolan-2-yl]-2,5-diisocyano-2,5-dimethyl-octahydronaphthalen-1-ol

8-[5-(2-chloropropan-2-yl)-2-methyloxolan-2-yl]-2,5-diisocyano-2,5-dimethyl-octahydronaphthalen-1-ol

C22H33ClN2O2 (392.223)


   

2-{[4-(3,4-dihydroxybutyl)-3,3,5-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[4-(3,4-dihydroxybutyl)-3,3,5-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

(2r,3r,4s,5s,6r)-2-{[(2r)-1-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(2r)-1-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

(2r,3r,4s,5s,6r)-2-{[(2s)-4-[(1r,4s,6s)-4-hydroxy-6-(hydroxymethyl)-2,2-dimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(2s)-4-[(1r,4s,6s)-4-hydroxy-6-(hydroxymethyl)-2,2-dimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

1-chloro-5-isocyano-8-[5-(2-isocyanopropan-2-yl)-2-methyloxolan-2-yl]-2,5-dimethyl-octahydronaphthalen-2-ol

1-chloro-5-isocyano-8-[5-(2-isocyanopropan-2-yl)-2-methyloxolan-2-yl]-2,5-dimethyl-octahydronaphthalen-2-ol

C22H33ClN2O2 (392.223)


   

(2r,3r,4s,5s,6r)-2-{[(2s)-1-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(2s)-1-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

4-[(3as,8as)-3a-hydroxy-1-methyl-2h,3h,8ah-pyrrolo[2,3-b]indol-8-yl]-3-[2-(dimethylamino)ethyl]-1h-indol-5-ol

4-[(3as,8as)-3a-hydroxy-1-methyl-2h,3h,8ah-pyrrolo[2,3-b]indol-8-yl]-3-[2-(dimethylamino)ethyl]-1h-indol-5-ol

C23H28N4O2 (392.2212)


   

(2e,4z)-n-(1-{[(1z)-1,3-dimethoxy-3-oxoprop-1-en-2-yl]-c-hydroxycarbonimidoyl}eth-1-en-1-yl)-2-methyldodeca-2,4-dienimidic acid

(2e,4z)-n-(1-{[(1z)-1,3-dimethoxy-3-oxoprop-1-en-2-yl]-c-hydroxycarbonimidoyl}eth-1-en-1-yl)-2-methyldodeca-2,4-dienimidic acid

C21H32N2O5 (392.2311)


   

2-{[1-hydroxy-4-(4-hydroxy-2,2,6-trimethylcyclohexyl)butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-hydroxy-4-(4-hydroxy-2,2,6-trimethylcyclohexyl)butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

(2r,3r,4s,5s,6r)-2-[(2s)-2-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-[(2s)-2-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

(1r,2r,5r,8s)-8-[(2r,5r)-5-chloro-2,6,6-trimethyloxan-2-yl]-1,5-diisocyano-2,8-dimethyl-octahydronaphthalen-2-ol

(1r,2r,5r,8s)-8-[(2r,5r)-5-chloro-2,6,6-trimethyloxan-2-yl]-1,5-diisocyano-2,8-dimethyl-octahydronaphthalen-2-ol

C22H33ClN2O2 (392.223)


   

6-[({4-[4-hydroxy-6-(hydroxymethyl)-2,2-dimethylcyclohexyl]butan-2-yl}oxy)methyl]oxane-2,3,4,5-tetrol

6-[({4-[4-hydroxy-6-(hydroxymethyl)-2,2-dimethylcyclohexyl]butan-2-yl}oxy)methyl]oxane-2,3,4,5-tetrol

C19H36O8 (392.241)


   

6-({[4-(3-hydroxybutyl)-5-(hydroxymethyl)-3,3-dimethylcyclohexyl]oxy}methyl)oxane-2,3,4,5-tetrol

6-({[4-(3-hydroxybutyl)-5-(hydroxymethyl)-3,3-dimethylcyclohexyl]oxy}methyl)oxane-2,3,4,5-tetrol

C19H36O8 (392.241)


   

(2r,3r,4s,5r,6r)-2-{[(2s)-1-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(2s)-1-hydroxy-4-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethylcyclohexyl]butan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

(2r,3r,4s,5r,6r)-2-{[(1s,4s,5r)-4-[(3s)-3,4-dihydroxybutyl]-3,3,5-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(1s,4s,5r)-4-[(3s)-3,4-dihydroxybutyl]-3,3,5-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

methyl (6e,8e,10e,12e,14e,16e,18e)-4,8,13,17-tetramethyl-20-oxohenicosa-2,4,6,8,10,12,14,16,18-nonaenoate

methyl (6e,8e,10e,12e,14e,16e,18e)-4,8,13,17-tetramethyl-20-oxohenicosa-2,4,6,8,10,12,14,16,18-nonaenoate

C26H32O3 (392.2351)


   

(2s,3s,4r,5r,6s)-2-{[(1s,4r,5s)-4-hydroxy-4-[(3s)-3-hydroxybutyl]-3,3,5-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3s,4r,5r,6s)-2-{[(1s,4r,5s)-4-hydroxy-4-[(3s)-3-hydroxybutyl]-3,3,5-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

(2r,3r,4s,5s,6r)-2-{[(1s,4r,5s)-4-[(3s)-3-hydroxybutyl]-5-(hydroxymethyl)-3,3-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,4r,5s)-4-[(3s)-3-hydroxybutyl]-5-(hydroxymethyl)-3,3-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

4-{3a-hydroxy-1-methyl-2h,3h,8ah-pyrrolo[2,3-b]indol-8-yl}-3-[2-(dimethylamino)ethyl]-1h-indol-5-ol

4-{3a-hydroxy-1-methyl-2h,3h,8ah-pyrrolo[2,3-b]indol-8-yl}-3-[2-(dimethylamino)ethyl]-1h-indol-5-ol

C23H28N4O2 (392.2212)


   

2-[2-hydroxy-4-(4-hydroxy-2,2,6-trimethylcyclohexyl)butoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[2-hydroxy-4-(4-hydroxy-2,2,6-trimethylcyclohexyl)butoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

5-hydroxy-12-methoxy-6-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 2-methylbut-2-enoate

5-hydroxy-12-methoxy-6-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 2-methylbut-2-enoate

C21H32N2O5 (392.2311)


   

(2r,3r,4s,5s,6r)-2-{[(1s,4s,5r)-4-[(3s)-3,4-dihydroxybutyl]-3,3,5-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,4s,5r)-4-[(3s)-3,4-dihydroxybutyl]-3,3,5-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)


   

(2r,3r,4s,5s,6r)-2-{[(1s,3s,4s,5r)-4-[(3r)-3-hydroxybutyl]-3-(hydroxymethyl)-3,5-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3s,4s,5r)-4-[(3r)-3-hydroxybutyl]-3-(hydroxymethyl)-3,5-dimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H36O8 (392.241)